Table 2.
Variables and values used in the sensitivity analyses
| Variable | Lower limit | Base-case scenario | Upper limit | Reasoning |
|---|---|---|---|---|
| Changing discount rate (base case 3% both costs and outcomes) | WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003. | |||
| Costs 0%, life-years 0% | 3% | Costs 6%, life-years 3% | ||
| Exchange rate (USD to INR) | 50 | 68.07 | Observed variation during the trial period | |
| Number of neo-natal deaths averted | 18 | 50 | 76 | The upper and lower limits of the 95% confidence interval of odds ratio of reduction in neo-natal mortality |
| Life-expectancy at birth (years) | 68.5a | 86 | Consistent with standard practice in economic assessment to take standard expected life expectancy. GBD-2010 | |
a Life expectancy at birth 2016 in India (http://www.indexmundi.com/india/life_expectancy_at_birth.html)